Mutual of America Capital Management LLC Has $1.05 Million Stake in OrthoPediatrics Corp. (NASDAQ:KIDS)

Mutual of America Capital Management LLC lessened its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 4.1% during the second quarter, Holdings Channel reports. The fund owned 36,463 shares of the company’s stock after selling 1,576 shares during the quarter. Mutual of America Capital Management LLC’s holdings in OrthoPediatrics were worth $1,049,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of KIDS. Braidwell LP increased its stake in OrthoPediatrics by 4.7% in the fourth quarter. Braidwell LP now owns 1,107,770 shares of the company’s stock valued at $36,014,000 after purchasing an additional 50,000 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of OrthoPediatrics by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock valued at $25,772,000 after buying an additional 11,100 shares during the period. Granahan Investment Management LLC increased its position in OrthoPediatrics by 30.0% in the 4th quarter. Granahan Investment Management LLC now owns 769,245 shares of the company’s stock valued at $25,008,000 after buying an additional 177,640 shares in the last quarter. Wasatch Advisors LP raised its stake in OrthoPediatrics by 21.2% during the 1st quarter. Wasatch Advisors LP now owns 501,310 shares of the company’s stock worth $14,618,000 after buying an additional 87,657 shares during the period. Finally, AWM Investment Company Inc. boosted its holdings in OrthoPediatrics by 14.6% in the first quarter. AWM Investment Company Inc. now owns 487,619 shares of the company’s stock worth $14,219,000 after acquiring an additional 62,000 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on KIDS shares. JMP Securities restated a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Friday, September 13th. Finally, Truist Financial restated a “hold” rating and set a $34.00 price objective (up previously from $30.00) on shares of OrthoPediatrics in a report on Friday, September 13th.

Insider Buying and Selling

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the completion of the sale, the general counsel now owns 77,304 shares in the company, valued at approximately $2,265,007.20. The transaction was disclosed in a document filed with the SEC, which is available at this link. 31.80% of the stock is owned by corporate insiders.

OrthoPediatrics Stock Down 0.3 %

KIDS stock opened at $26.16 on Friday. The firm has a market capitalization of $623.37 million, a PE ratio of -27.25 and a beta of 1.18. The company has a quick ratio of 1.96, a current ratio of 4.90 and a debt-to-equity ratio of 0.03. OrthoPediatrics Corp. has a twelve month low of $23.10 and a twelve month high of $36.23. The stock’s 50 day moving average is $30.00 and its 200-day moving average is $30.17.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Monday, August 5th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.08. OrthoPediatrics had a negative return on equity of 5.44% and a negative net margin of 14.35%. The business had revenue of $52.80 million for the quarter, compared to analysts’ expectations of $52.40 million. Sell-side analysts expect that OrthoPediatrics Corp. will post -0.92 EPS for the current fiscal year.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.